Biomarkers Market Research Reports & Industry Analysis
Biomarkers are measurable indicators, such as molecules or genetic mutations, that provide information about a biological process, condition, or disease in the body. As healthcare evolves, it's important to grasp the impact and unique dynamics of this industry. At MarketResearch.com, we understand the need for reliable data on this sector. Our biomarkers market research reports provide a comprehensive and informative analysis, empowering you to navigate this dynamic industry with greater confidence.
Biomarkers Industry Insights
- Our research covers diverse markets so you can quickly and easily find research on segments big and small.
- Through our platform, you can access essential data to drive strategic decisions, from biomarkers market sizing and growth projections to key drivers and challenges.
- Use our research to better understand products under development, market trends, competitor analysis, and leading players.
Harnessing MarketResearch.com's Expertise
For more than twenty years, MarketResearch.com has been a leader in the field of market research, serving a diverse clientele that includes top investment banks, management consulting firms, and multinational corporations. We are known for providing reliable insights and offer a centralized platform with access to reports from numerous firms. In addition, our research specialists are available to provide expert guidance and support every step of the way.
Biomarkers Industry Research & Market Reports
-
Global Digital Biomarker Market Growth (Status and Outlook) 2022-2028
... 387.24 million in 2021, at a CAGR of 82.53% during 2022-2028. Fully considering the economic change by this health crisis, Passive Digital Biomarker accounting for 65.55% of the Digital Biomarker global market in 2021, is ... Read More
-
Blood Based Biomarker Market, By Type (Screening Biomarker, Diagnosis Biomarker, and Others), By Disease (Cancer, Neurological Disorders, and Others), By Application (Diagnostics, Drug Discovery, and Personalized Medicine), and By Region (North America, Latin America, Europe, Asia-Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Asia-Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 The term biomarker, or biological marker, refers to a broad range of measures that capture what is happening in a ... Read More
-
Global Renal Biomarkers Market - 2021-2028
... CAGR of XX% during the forecast period (2021-2028). The renal biomarkers are the biomarkers that help to diagnose or identify the patients at risk of developing kidney diseases, by measuring their blood or urine levels. ... Read More
-
2022 Global: Cancer Biomarkers - Innovative Markets Forecast (2028) report
... 2028. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2017 to 2028 using regression analysis in ... Read More
-
2022 Global: Cellular Health Screening/Health Testing - Innovative Markets Forecast (2028) report
... the period 2017 through 2028. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2017 to 2028 ... Read More
-
Metabolomics Global Market Report 2022 Including: 1) By Product & Service: Metabolomics Instruments; Metabolomics Bioinformatics Tools & Services 2) By Application: Biomarker Discovery; Drug Discovery; Toxicology Testing; Nutrigenomics; Functional Genomics; Personalized Medicine; Others 3) By Indication: Cancer; Cardiovascular Disorders; Neurological Disorders; Inborn Errors of Metabolism; Others 4) By Metabolomics Instruments: Separation Techniques; Detection Techniques 5) By Metabolomics Bioinformatics Tools & Services: Bioinformatics Tools and Database; Bioinformatics Services Covering: Human Metabolome Technologies; Metabolon; Bio-Rad Laboratories; Bruker; Agilent Technologies; Thermo Fisher; Waters
... which is experiencing strong growth. The report gives a guide to the metabolomics market which will be shaping and changing our lives over the next ten years and beyond, including the market's response to the ... Read More
-
Global Cardiac Marker Analyzer Market and Forecast, Impact of COVID-19, Product Analysis, Companies Business & Marketing Strategy, Major Deals
... Marker analyzer represents a paradigm in diagnostics that provides high sensitivity and reliable information in minutes. The cardiac biomarkers that are widely used as an integrated diagnostic approach for CVDs include CK-MB, troponin I and ... Read More
-
Sepsis Diagnostics Market by Technology (Microbiology, PCR, Sequencing, Biomarkers), Product (Reagents, Assay, Instruments, Software), Test Type (Lab, POC), Pathogen (Bacterial, Viral, Fungal), End User (Hospital, Pathology Lab) - Global Forecast to 2026
... diagnostics market size is expected to reach USD 771 million by 2026 from USD 503 million in 2021, at a CAGR of 8.9%. The demand is expected to grow due to the rising incidence of ... Read More
-
Asia-Pacific Cancer Biomarkers Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... a paradigm shift in healthcare, from diagnosis, after the symptoms have appeared, to early diagnosis or risk assessment, especially in countries, such as China, India, Japan, etc. Cancer is one of the leading causes of ... Read More
-
United States Cancer Biomarkers Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... treatments for cancer in the country and increasing usage of biomarkers in drug development. The rising number of cancer cases is creating tremendous opportunities for market players. The major market players are focusing on R&D ... Read More
-
Genomic Biomarkers Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... diseases (cardiovascular diseases, cancer, strokes, and arthritis), high demand for minimally invasive procedures, technological advancements, development in R&D, and the infrastructure for data sharing and the demand for personalized medicines are expected to drive the ... Read More
-
Europe Cancer Biomarkers Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... of approximately USD 4,008 million in 2020, and it is expected to reach USD 7,764 million by 2026. Certain factors driving the growth of the market include the increased burden of cancer and the increasing ... Read More
-
2022 Global Forecast for Cancer/Tumor Profiling (2023-2028 Outlook)-High Tech & Emerging Markets Report
... global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product shipments ... Read More
-
2022 Global Forecast for Cancer Biomarkers (2023-2028 Outlook)-High Tech & Emerging Markets Report
... global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product shipments ... Read More
-
Cardiac Biomarkers Testing Devices - Market Insights, Competitive Landscape and Market Forecast-2026
... Others]), By Application (Acute Coronary Syndrome, Congestive Heart Failure, Myocardial Infarction, And Others) And By End User (Hospitals, Pathology Labs, And Others), by geography is expected to grow at a steady CAGR forecast till 2026 ... Read More
-
Liquid Biopsy in Cancer Diagnostics - Market Insights, Competitive Landscape and Market Forecast-2026
... And Saliva), By Biomarker Type (Circulating Tumor Cells, Circulating Tumor DNA, Circulating Free DNA, And Others), By Cancer Type (Lung Cancer, Breast Cancer, Colon Cancer, And Others), By Technique (Polymerase Chain Reaction And Next Generation ... Read More
-
The Market for Liquid Biopsy
... Biopsy by Region The Market for Liquid Biopsy Market by Type of Analyte The Market for CTC-based Liquid Biopsy The Market for ctDNA-based Liquid Biopsy The Market for EV and Exosome-based Liquid Biopsy The Market ... Read More
-
World Market for Cardiac Markers (POC and Lab-Based)
... incidence of cardiovascular disease going through the roof, Kalorama Information’s report, World Market for Cardiac Markers (POC and Lab-Based), covers why cardiac markers are in huge demand and a constant subject of research for improvement. ... Read More
-
Liquid Biopsy for Cancer Diagnostics – Competitive Landscape and Pipeline Analysis, 2022
... Diagnostics market in the 7 major pharmaceutical markets. The report also gives a brief competitive analysis of both the current and emerging products, to help understand the competition in the market. Liquid Biopsy for Cancer ... Read More
-
Biomarkers Market: Current Analysis and Forecast (2021-2027)
... during the forecast period (2021-2027). Biological molecules found in blood, tissues or other body fluids which is a sign of normal or abnormal process or of a condition or disease. A biomarker can be used ... Read More
-
The World Market for Cancer Diagnostics, 2021
... cancer recurrence. The World Market for Cancer Diagnostics, as well as relevant industry merger data provided by Kalorama Information, provides authoritative and complete analysis of the cancer testing industry, with expert market sizing and opportunity ... Read More
-
The World Market for Diagnostic Biomarkers (Tumor, Cardiac, Infectious Disease, AutoImmune, Others)
... likely biological response. Biomarkers can be used for a range of diagnostic applications including diagnosis, predicting prognosis, identifying appropriate therapy for an individual, monitoring disease or for return of a disease, and other applications. This ... Read More
-
Companion Diagnostics in the COVID-19 Era: Market Analysis and Opportunities
... in oncology, companion diagnostics are rising to the forefront of pharmaceutical development and treatment. Companion diagnostics increase the probability of clinical success by identifying patients with the presence of biomarkers or disease-specific therapeutic targets that ... Read More
-
Artificial Intelligence Markets in IVD
... market and many more are in development. In recent years, diagnostics companies – in collaboration with AI companies – have begun implementing increasingly sophisticated machine learning techniques to improve the power of data analysis for ... Read More
-
The World Market for Biomarkers (Cardiac Markers [cTn, HscTn, Acute CK-MB/BNP, Others], Tumor Markers [PSA, CEA, CA 125, AFP, PSA Rapid, Others], Coagulation Markers [PT/INR, D-dimer], Infectious Disease Markers [by Disease], Immunological Disease Markers [Autoimmune/Allergy], Neurological Markers, C-Reactive Protein and Other Markers)
... Markers, C-Reactive Protein and Other Markers) Biomarkers are biological or biochemical molecules, genetic changes, or other characteristics that can be measured; they indicate or predict a condition, risk, or likely biological response. Biomarkers can be ... Read More
Research Assistance
